Clinical Pharmacist’s Role in Optimizing Therapy through Drug-Related Problems Identification

Liana Debora, Eni Susanti, Suharjono Suharjono

Abstract


Clinical pharmacists play an important role in a clinical setting as part of a team. Drug-related problem (DRP) is the main part pharmacist should focus on to achieve the optimal therapy for patients. Therefore, this study aimed to investigate the role of clinical pharmacy in a private hospital of West Java, Indonesia, and describe the prevalence of DRPs and several factors associated with the risk of DRPs. The clinical pharmacist's monthly report was obtained from June to August 2020. Furthermore, problems, causes, and types of DRP were identified using PCNE Classification V9.1. Drug classes and other factors related to DRP were also investigated. This was a descriptive study with a retrospective approach to medical records, where 240 DRPs were identified in 157 patients. Approximately 4.45% experienced DRP, especially in ICU at 45.83% and Stroke Unit or SU-IC at 25.42%. The most common DRPs were incomplete drug treatment, drug interaction, and dose adjustment. Antimicrobial, cardiovascular agents, and PPI were the most commonly involved. In the linear regression analysis, length of stay and number of therapy significantly affect DRP. In this study, pharmacists intervented each DRP, with 57% accepted as fully and partially implemented by the physicians. A total of 22% of interventions ended with unknown status due to limited follow-up time. Meanwhile, reviews on medication by clinical pharmacists lead to improvement in drug treatment. The implementation of clinical pharmacy services shows many DRPs to be prevented and increases therapy optimization.

Keywords: Clinical pharmacist, drug-related problems, drugs, hospital, intervention

 

Peran Farmasis Klinis dalam Optimalisasi Pengobatan melalui Identifikasi Permasalahan Obat 

Abstrak

Farmasis klinik memiliki peran penting dalam tim di RS terutama dalam mencapai terapi optimal bagi pasien melalui penanganan drug related problems (DRP). Tujuan penelitian ini adalah untuk mengetahui peran farmasis klinik di salah satu RS swasta di Jawa Barat dan faktor risiko terjadinya DRP. Data dari laporan farmasi klinik diambil pada bulan Juni–Agustus 2020. Identifikasi permasalahan, penyebab, jenis DRP dilakukan berdasarkan PCNE Classification V9.1. Golongan obat dan faktor lain yang menyebabkan DRP juga dikaji. Studi ini berupa penelitian deskripsi dengan pendekatan retrospektif berdasarkan rekam medik pasien. Farmasis mengidentifikasi 240 DRP pada 157 pasien rawat inap. Sekitar 4,45% pasien di RS berpotensi mengalami DRP, terutama yang dirawat di ruang perawatan intensif (45,83%) dan unit strok (25,42%). DRP yang paling sering terjadi adalah terapi obat kurang tepat, interaksi obat, dan perlunya penyesuaian dosis. Antimikroba, obat kardiovaskular, dan PPI merupakan obat yang paling sering menyebabkan DRP. Pada analisis statistik menggunakan regresi linier, lama perawatan dan jumlah jenis obat signifikan menyebabkan DRP. Farmasis menyampaikan usulan kepada dokter (>70% kasus). Sebanyak 22% usul berakhir dengan status yang tidak diketahui karena kurangnya waktu untuk follow up usul kepada dokter. Tingkat penerimaan usul yaitu 57%, baik yang diterima sepenuhnya maupun diterima sebagian. Pengkajian pengobatan pasien mendorong beberapa perbaikan terapi obat. Penerapan layanan farmasi klinis dapat mendeteksi dan mencegah DRP sehingga mengoptimalkan pengobatan pasien.   

Kata kunci: Drug-related problems, farmasis klinik, intervensi, obat, rumah sakit


Keywords


Clinical pharmacist; drug-related problems; drugs; hospital; intervention

Full Text:

PDF

References


Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 Tentang Standar Pelayanan Kefarmasian di Rumah Sakit [Accessed on: 17 November 2020]. Available at: https://peraturan.bpk.go.id/Home/Details/1144 91/permenkes-no-72-tahun-2016

Pharmaceutical Care Network Europe. Classification for drug related problems V9.1. 2020. [Accessed on: 5 October 2020] Available at: http://www.pcne.org/

Rodrigues JPV, Marques FA, Goncalves AMRF, Campos MSdA, Reis TMd, Morelo MRS, et al. Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital. PLoS One. 2019;14(1):e0210779. doi: 10.1371/journal.pone.0210779

Sekhar MS, Mary CA, Anju PG, Hamsa NA. Study on drug related admissions in a tertiary care hospital in South India. Saudi Pharm J. 2011;19(4):273–8. doi: 10.1016/j.jsps.2011.04.004

Darmawan E, Ahmad H, Perwitasari DA, Kusumawardan N. Pharmacist intervention can reduce the potential use of inappropriate drugs medications in Indonesian geriatric patients. J App Pharm Sci. 2020;10(1):88–95. doi: 10.7324/JAPS.2020.101012

Johansen ET, Haustreis SM, Mowinckel AS, Ytrebø LM. Effects of implementing a clinical pharmacist service in a mixed Norwegian ICU. Eur J Hosp Pharm. 2016;23(4):197–202. doi: 10.1136/ejhpharm-2015-000751

Peterson C, Gustafsson M. Characterization of drug-related problems and associated factors at a clinical pharmacist service-naive hospital in Northern Sweden. Drugs Real World Outcomes. 2017;4(2):97–107. doi: 10.1007/s40801-017-0108-7

Ramanath K, Nedumballi S. Assessment of medication-related problems in geriatric patients of a rural tertiary care hospital. J Young Pharm. 2012;4(4):273–8. doi: 10.4103/0975-1483.104372

Greeshma M, Lincy S, Maheswari E, Shankar T, Viswam SK. Identification of drug related problems by clinical pharmacist in prescriptions with polypharmacy: A prospective interventional study. J Young Pharm. 2018;10(4):460–5. doi: 10.5530/jyp.2018.10.100

Puumalainen E, Airaksinen M, Jalava SE, Chen TF, Dimitrow M. Comparison of drug-related problem risk assessment tools for older adults: A systematic review. Eur J Clin Pharmacol. 2020;76(3):337–48. doi: 10.1007/s00228-019-02796-w

Azrifitria, Fauziyah S, Nur A. The impact of pharmacists’ interventions to prevent medication errors at a tertiary hospital in Central Jakarta, Indonesia. Pharmaceut Biomed Sci J. 2019;1(1):1–6.

Soheil R, Kaveh E, Farhad N, Mandana I, Elham H, Reza G. Validating a drug related problems classification system in outpatient setting in Iran. JJ Res Pharm Pract. 2018;7(3):117–22. doi: 10.4103/jrpp.JRPP_18_17

Roblek T, Deticek A, Leskovar B, Suskovic S, Horvat M, Belic A, et al. Clinical-pharmacist intervention reduces clinically relevant drug–drug interactions in patients with heart failure: A randomized, double-blind, controlled trial. Int J Cardiol. 2016;203:647–52. doi: 10.1016/j.ijcard.2015.10.206

Alshehri AA, Jalal Z, Cheema E, Haque MS, Jenkins D, Yahyouche A. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta-analysis of randomised controlled trials. Br J Clin Pharmacol. 2020;86(1):29–38. doi: 10.1111/bcp.14164

Semcharoen K, Supornpun S, Nathisuwan S, Kongwatcharapong J. Characteristic of drug related problems and pharmacists’ interventions in a SU-IC in Thailand. Int J Clin Pharm. 2019;41(4):880–7. doi: 10.1007/s11096-019-00832-4

Guignard B, Bonnabry P, Perrier A, Dayer P, Desmeules J, Samer CF. Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologist. Eur J Intern Med. 2015;26(6):399–406. doi: 10.1016/j.ejim.2015.05.012

Renaudin P, Coste A, Audurier Y, Berbis H, Canovas F, Jalabert A, et al. Clinical, economic, and organizational impact of the clinical pharmacist in an Orthopedic and Trauma Surgery Department. J Patient Saf. 2021;17(8):e1507–13. doi: 10.1097/PTS.0000000000000539

Sagita VA, Bahtiar A, Andrajati R. Evaluation of a clinical pharmacist intervention on clinical and drug-related problems among coronary heart disease inpatients: A pre-experimental prospective study at a general hospital in Indonesia. Sultan Qaboos Univ Med J. 2018;18(1):e81–7. doi: 10.18295/squmj.2018.18.01.013

Zaal RJ, den Haak EW, Andrinopoulou ER, van Gelder T, Vulto AG, van den Bernt P. Physicians’ acceptance of pharmacists’ interventions in daily hospital practice. Int J Clin Pharm. 2020;42(2):141–9. doi: 10.1007/s11096-020-00970-0

de Grégori J, Pistre P, Boutet M, Porcher L, Devaux M, Pernot C, et al. Clinical and economic impact of pharmacist interventions in an ambulatory hematology–oncology department. J Oncol Pharm Practice. 2020;36(5):1172–9. doi: 10.1177/1078155220915763

Qin S-B, Zhang X-Y, Fu Y, Nie X-Y, Liu J, Shi L-W, et al. The impact of the clinical pharmacist led interventions in China: A systematic review and meta analysis. Int J Clin Pharm. 2020;42(2):366–77. doi: 10.1007/s11096-020-00972-y



Digital Object Identifier

DOI : https://doi.org/10.15416/ijcp.2021.10.4.303


Dimension Citation Metrics Badge

Refbacks

  • There are currently no refbacks.


 Indonesian Journal of Clinical Pharmacy is indexed by

        

  Creative Commons License

IJCP by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 

View My Stats